Published in Cancer Weekly, October 12th, 2004
"The aim of this study was to determine the prognostic value of Ki-67 immunostaining in laryngeal squamous cell carcinomas. Ki-67 labeling was quantified in 63 laryngeal squamous cell carcinomas by counting at least 1000 tumor cells in the most immunoreactive area in each sample, and the Ki-67 labeling index was calculated as a percentage," scientists writing in the journal European Archives of Oto - Rhino - Laryngology report.
"The antigen expression was compared with clinical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.